FENNEC PHARMACEUTICALS INC. — Director's Dealing 2023

Jun 30, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2023-06-28

Reporting Person: Andrade Robert (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-28	Common shares	S	10000	$8.99	Disposed	139721	Direct
2023-06-29	Common shares	S	7500	$8.97	Disposed	132221	Direct
2023-06-30	Common shares	S	7500	$8.82	Disposed	124721	Direct
2023-06-30	Common shares	M	25000	$2.45	Acquired	149721	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-30	Common Shares	$2.45	M	25000	Disposed	2026-07-05	Options (25000)	Direct

Footnotes

F1: Represents shares sold pursuant to a 10b5-1 plan on June 28, 2023.

F2: Represents shares sold pursuant to a 10b5-1 plan on June 29, 2023.

F3: Represents shares sold pursuant to a 10b5-1 plan on June 30, 2023.

F4: Shares aquired through the exercise of option contract with a strike price of $2.45 and an expiration date of July 5, 2026.

F5: Represents options granted on July 5, 2016, with a strike price of $2.45 and expiration date of July 5, 2026.